phenox GmbH, announces participation in the SITS Open clinical trial where pREset and pREset LITE Thrombectomy Devices have been included in the study device portfolio, one of only three devices to be used in the study.Stroke is the second leading cause of death worldwide and the most common cause of adult disability in the western world.  Ischemic stroke, caused by a blocked artery, is the most common type of stroke and it takes only minutes without oxygen for brain damage to occur and more brain cells die every minute that flow is blocked. The aim of physicians is to restore blood flow by opening the blocked artery as quickly as possible...

continue reading